新医改背景下制药企业如何实现可持续发展（）.docVIP

新医改背景下制药企业如何实现可持续发展（） The new medical reform has entered a crucial stage, the competition of pharmaceutical industry has entered the competition between enterprises as the core of industrial value chain stage, most of the enterprise marketing confusion is no longer a partial and superficial, but systematic and substantial. Like the wooden barrel principle, the shortage of any plate will affect and restrict the whole development and even survive. From the lack of marketing strategy, the key elements of the product, model, market, channels and terminals such as planning chaos, to the construction of marketing organization and execution of God is seemingly weak, pharmaceutical companies need in the marketing strategy and ability construction is not a simple system of tinkering, but the transformation and upgrading! 1, the leading strategy and counsel of action In the new medical reform background, pharmaceutical enterprises must fully examine the changes in the external environment opportunities and challenges, the correct evaluation of their own resources and capabilities, deep thinking and system planning for the future development strategy for the development of business marketing, product strategy, marketing strategy, channel strategy and marketing strategy in the terminal under the guidance of the competition strategy. At the same time, the improvement of enterprise marketing mode, and strengthen the development of marketing organization system, build a strong executive force through the organization construction and ideological construction. In the field of marketing strategy and planning, leading competitors will be able to win over competitors in sales, management and execution, and strategy leading and action winning will be the foundation for pharmaceutical enterprises to win in the future market competition. For enterprises, if we want to achieve strategic leadership, we must first understand the enterprise strategy correctly. And Jun consulting, using three